Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-04-20

Clinical Trial Update: Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Endostatin in combination with Oxaliplatin and radiotherapy for esophageal cancer; the trial's status is currently unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Endostatin (endostatin)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Hangzhou Cancer Hospital | Conditions: Esophageal Cancer, Endostatin | Phase 2 | Status: UNKNOWN